LA
Leila Alland
Director

Leila Alland insider trades: Abeona Therapeutics (ABEO) stock buys and sales

Director, Abeona Therapeutics Last trade Jun 30, 2026 22 Form 4 filings
$157K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2021
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Leila reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 30, 2026ABEO↓ Sell$65K
Feb 2, 2026ABEO↓ Sell$92K
May 16, 2024ABEO↑ Buy$52K
Sep 27, 2023ABEO↓ Sell$28K
Sep 15, 2023PMVP↓ Sell$42K
Sep 9, 2021PMVP↓ Sell$3K
Sep 7, 2021PMVP↓ Sell$118K
Aug 9, 2021PMVP↓ Sell$152K
Jul 7, 2021PMVP↓ Sell$129K
Jun 7, 2021PMVP↓ Sell$134K
May 7, 2021PMVP↓ Sell$139K
Apr 7, 2021PMVP↓ Sell$135K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ABEO insiders

Open-market trades in the last 12 months

About Leila Alland's insider trades

Leila Alland is a director at Abeona Therapeutics (ABEO). Since Apr 7, 2021, Leila has reported 1 open-market purchase worth $52K and 11 sales worth $1.0M on SEC Form 4. In the last 12 months: 2 sales ($157K).

Their filings also include grants and awards (11 filings), option exercises (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.